Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Trends in mortality of hospitalised COVID-19 patients: A single centre observational cohort study from Spain.
Garcia-Vidal C, Cózar-Llistó A, Meira F, Dueñas G, Puerta-Alcalde P, Cilloniz C, Garcia-Pouton N, Chumbita M, Cardozo C, Hernández M, Rico V, Bodro M, Morata L, Castro P, Almuedo-Riera A, García F, Mensa J, Antonio Martínez J, Sanjuan G, Torres A, Nicolás JM, Soriano A; COVID-19-researcher group. Garcia-Vidal C, et al. Among authors: cozar llisto a. Lancet Reg Health Eur. 2021 Apr;3:100041. doi: 10.1016/j.lanepe.2021.100041. Epub 2021 Jan 24. Lancet Reg Health Eur. 2021. PMID: 33870249 Free PMC article.
Impact of Inflammatory Response Modifiers on the Incidence of Hospital-Acquired Infections in Patients with COVID-19.
Meira F, Moreno-García E, Linares L, Macaya I, Tomé A, Hernández-Meneses M, Albiach L, Morata L, Letona L, Bodro M, Cózar-Llistó A, Cardozo C, Chumbita M, Pitart C, Ambrosioni J, Rico V, Agüero D, Puerta-Alcalde P, Garcia-Pouton N, Marco F, Garcia-Vidal C, Soriano A, Martínez JA. Meira F, et al. Among authors: cozar llisto a. Infect Dis Ther. 2021 Sep;10(3):1407-1418. doi: 10.1007/s40121-021-00477-9. Epub 2021 Jun 11. Infect Dis Ther. 2021. PMID: 34115314 Free PMC article.
Real-life use of remdesivir in hospitalized patients with COVID-19.
Garcia-Vidal C, Meira F, Cózar-Llistó A, Dueñas G, Puerta-Alcalde P, Garcia-Pouton N, Chumbita M, Cardozo C, Hernandez-Meneses M, Alonso-Navarro R, Rico V, Agüero D, Bodro M, Morata L, Jordan C, Lopera C, Ambrosioni J, Segui F, Grafia N, Castro P, García F, Mensa J, Martínez JA, Sanjuan G, Soriano A; COVID19-researcher group. Garcia-Vidal C, et al. Among authors: cozar llisto a. Rev Esp Quimioter. 2021 Apr;34(2):136-140. doi: 10.37201/req/018.2021. Epub 2021 Mar 6. Rev Esp Quimioter. 2021. PMID: 33675220 Free PMC article.
Experience with the use of siltuximab in patients with SARS-CoV-2 infection.
Meira F, Albiach L, Carbonell C, Martín-Oterino JA, Martín-Ordiales M, Linares L, Macaya I, Agüero D, Ambrosioni J, Bodro M, Cardozo C, Chumbita M, De la Mora M, García-Pouton N, Garcia-Vidal C, González-Cordón A, Hernández-Meneses M, Inciarte A, Laguno M, Leal L, Morata L, Puerta-Alcalde P, Rico V, Letona L, Cózar-Llistó A, Dueñas G, Solá M, Torres B, Rojas J, Moreno A, Moreno-García E, Torres M, Martínez JA, Soriano A, García F. Meira F, et al. Among authors: cozar llisto a. Rev Esp Quimioter. 2021 Aug;34(4):337-341. doi: 10.37201/req/045.2021. Epub 2021 May 13. Rev Esp Quimioter. 2021. PMID: 33982984 Free PMC article.
Predicting critical illness on initial diagnosis of COVID-19 based on easily obtained clinical variables: development and validation of the PRIORITY model.
Martínez-Lacalzada M, Viteri-Noël A, Manzano L, Fabregate M, Rubio-Rivas M, Luis García S, Arnalich-Fernández F, Beato-Pérez JL, Vargas-Núñez JA, Calvo-Manuel E, Espiño-Álvarez AC, Freire-Castro SJ, Loureiro-Amigo J, Pesqueira Fontan PM, Pina A, Álvarez Suárez AM, Silva-Asiain A, García-López B, Luque Del Pino J, Sanz-Cánovas J, Chazarra-Pérez P, García-García GM, Núñez-Cortés JM, Casas-Rojo JM, Gómez-Huelgas R; SEMI-COVID-19 Network. Martínez-Lacalzada M, et al. Clin Microbiol Infect. 2021 Dec;27(12):1838-1844. doi: 10.1016/j.cmi.2021.07.006. Epub 2021 Jul 15. Clin Microbiol Infect. 2021. PMID: 34274525 Free PMC article.
Characteristics of Clostridium difficile infection in patients with discordant diagnostic test results.
Ramos Martínez A, Ortiz Balbuena J, Asensio Vegas Á, Sánchez Romero I, Múñez Rubio E, Cantero Caballero M, Cózar Llistó A, Portero Azorín F, Martínez Ruiz R. Ramos Martínez A, et al. Among authors: cozar llisto a. Rev Esp Enferm Dig. 2016 Jun;108(6):304-8. doi: 10.17235/reed.2016.4052/2015. Rev Esp Enferm Dig. 2016. PMID: 27033878 Free article.
Prediction of recurrent clostridium difficile infection at the bedside: the GEIH-CDI score.
Cobo J, Merino E, Martínez C, Cózar-Llistó A, Shaw E, Marrodán T, Calbo E, Bereciartúa E, Sánchez-Muñoz LA, Salavert M, Pérez-Rodríguez MT, García-Rosado D, Bravo-Ferrer JM, Gálvez-Acebal J, Henríquez-Camacho C, Cuquet J, Pino-Calm B, Torres L, Sánchez-Porto A, Fernández-Félix BM; Nosocomial Infection Study Group. Cobo J, et al. Among authors: cozar llisto a. Int J Antimicrob Agents. 2018 Mar;51(3):393-398. doi: 10.1016/j.ijantimicag.2017.09.010. Epub 2017 Sep 20. Int J Antimicrob Agents. 2018. PMID: 28939450